Purchases and Sales Made in Q3 2024 in Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN) during Q3 2024. The information is specifically focused on institutions that hold shares of UroGen Pharma Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-100K- 6.06% |
$1.27M - $1.79M
|
1.55M
$23.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-124K- 49.96% |
$1.58M - $2.22M
|
124K
$1.92M
|
|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-145K- 83.55% |
$1.85M - $2.6M
|
28.6K
$441K
|
|
|
Nov 14, 2024
Q3 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-201K- 18.23% |
$2.55M - $3.6M
|
901K
$13.9M
|
|
|
Nov 12, 2024
Q3 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-303K- 14.43% |
$3.85M - $5.43M
|
1.8M
$27.7M
|
|
|
Nov 14, 2024
Q3 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-943K- 38.49% |
$12M - $16.9M
|
1.51M
$23.2M
|
|
|
Nov 13, 2024
Q3 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-2.15M- 73.89% |
$27.3M - $38.5M
|
759K
$11.7M
|